BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4922320)

  • 21. Psychological presentations without hepatic involvement in Wilson disease.
    Lin JJ; Lin KL; Wang HS; Wong MC
    Pediatr Neurol; 2006 Oct; 35(4):284-6. PubMed ID: 16996405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Laboratory changes and complications during long-term therapy of Wilson's disease using D-penicillamine].
    Hauftová D; Slavícek J; Hartl J; Seidlová V; Komenda S
    Vnitr Lek; 1970 Apr; 16(4):344-53. PubMed ID: 5443326
    [No Abstract]   [Full Text] [Related]  

  • 23. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine].
    D'Addabbo A; Damato VD; Germinario L; Campanella G; Boccuni N
    Acta Neurol (Napoli); 1971; 26(4):436-48. PubMed ID: 5132825
    [No Abstract]   [Full Text] [Related]  

  • 24. Alpha lipoic acid: a novel treatment for depression.
    Salazar MR
    Med Hypotheses; 2000 Dec; 55(6):510-2. PubMed ID: 11090300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical applications of alpha-lipoic acid in the management of neurological disorders besides carpal tunnel syndrome.
    Kapoor S
    Eur Rev Med Pharmacol Sci; 2009; 13(5):401-2. PubMed ID: 19961049
    [No Abstract]   [Full Text] [Related]  

  • 26. [Lipoic acid as a means of metabolic therapy of open-angle glaucoma].
    Filina AA; Davydova NG; Endrikhovskiĭ SN; Shamshinova AM
    Vestn Oftalmol; 1995; 111(4):6-8. PubMed ID: 8604540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [On the pathogenesis and therapy of Wilson's disease. The effect of alpha-lipoic acid (preliminary communication)].
    da COSTA S; RODRIGUES EM; da SILVA J; RELVAS ME; HALPERN MJ
    Arzneimittelforschung; 1960 May; 10():333-9. PubMed ID: 13695801
    [No Abstract]   [Full Text] [Related]  

  • 28. Tissue copper, zinc, and manganese levels in Wilson's disease: studies with the use of neutron activation analysis.
    Yeh SJ; Leu ML; Strickland GT
    J Lab Clin Med; 1971 Mar; 77(3):438-44. PubMed ID: 5553728
    [No Abstract]   [Full Text] [Related]  

  • 29. Therapeutic efficacy of DL-alpha-lipoic acid on cyclosporine A induced renal alterations.
    Amudha G; Josephine A; Mythili Y; Sundarapandiyan R; Varalakshmi P
    Eur J Pharmacol; 2007 Oct; 571(2-3):209-14. PubMed ID: 17619014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wilson disease in children: analysis of 57 cases.
    Manolaki N; Nikolopoulou G; Daikos GL; Panagiotakaki E; Tzetis M; Roma E; Kanavakis E; Syriopoulou VP
    J Pediatr Gastroenterol Nutr; 2009 Jan; 48(1):72-7. PubMed ID: 19172127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The renal clearance of amino acids in a patient with Wilson's disease during penicillamine treatment.
    Bell GE; Slivka DC; Huston JR
    J Lab Clin Med; 1968 Jan; 71(1):113-21. PubMed ID: 5634999
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of hepatolenticular degeneration. (Wilson's disease).
    Spellberg MA
    Am J Gastroenterol; 1969 Aug; 52(2):121-6. PubMed ID: 4979739
    [No Abstract]   [Full Text] [Related]  

  • 33. [Penicillamine treatment of Wilson's disease].
    Falkmer S; Samuelson G; Sjölin S
    Lakartidningen; 1969 May; 66(20):2097-105. PubMed ID: 5795695
    [No Abstract]   [Full Text] [Related]  

  • 34. [Acute hemolytic crisis as the initial manifestation of Wilson disease].
    Rath HC; Enger IM; Rüschoff J; Schölmerich J; Holstege A
    Z Gastroenterol; 1997 Mar; 35(3):199-203. PubMed ID: 9173689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Aggressive behavior, increasing loss of independence in mentally retarded patient].
    Dukas L; Vogt M
    Praxis (Bern 1994); 1996 May; 85(21):696-8. PubMed ID: 8685565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wilson's disease: an update.
    Garg RK; Nag D
    J Assoc Physicians India; 1995 May; 43(5):351-5. PubMed ID: 9081968
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies on the effect of alpha-lipoic acid on disturbances in histidine metabolism.
    Galamon T; Szulc-Kuberska J; Tronczyńska J
    Pol Med J; 1971; 10(1):31-5. PubMed ID: 4929904
    [No Abstract]   [Full Text] [Related]  

  • 38. [Wilson's disease (hepatolenticular degeneration)].
    Ferrer S; Grismali J; Vergara F; Madrid R; Colombo M
    Rev Med Chil; 1968 Dec; 96(12):779-88. PubMed ID: 5732518
    [No Abstract]   [Full Text] [Related]  

  • 39. [Diagnosis of Wilson's disease in 1981].
    Sternlieb I
    Gastroenterol Clin Biol; 1981 Feb; 5(2):169-74. PubMed ID: 7009305
    [No Abstract]   [Full Text] [Related]  

  • 40. A randomized double-blind placebo-controlled trial of thioctic acid in migraine prophylaxis.
    Magis D; Ambrosini A; Sándor P; Jacquy J; Laloux P; Schoenen J
    Headache; 2007 Jan; 47(1):52-7. PubMed ID: 17355494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.